Business Description
Sudarshan Pharma Industries Ltd
ISIN : INE00TV01023
Total Employee Number:
60Compare
Compare
Traded in other countries / regions
543828.India IPO Date
2023-03-22Description
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 1.82 | |||||
Debt-to-EBITDA | 4.75 | |||||
Interest Coverage | 1.85 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.74 | |||||
Beneish M-Score | -1.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.6 | |||||
3-Year EBITDA Growth Rate | 28.9 | |||||
3-Year EPS without NRI Growth Rate | 20 | |||||
3-Year FCF Growth Rate | 3.6 | |||||
3-Year Book Growth Rate | 15.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 10.93 | |||||
9-Day RSI | 21.61 | |||||
14-Day RSI | 29.96 | |||||
3-1 Month Momentum % | 27.39 | |||||
6-1 Month Momentum % | 70.95 | |||||
12-1 Month Momentum % | 29.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 0.6 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 105.49 | |||||
Days Sales Outstanding | 98.59 | |||||
Days Payable | 80.73 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 11.9 | |||||
Operating Margin % | 6.76 | |||||
Net Margin % | 3.3 | |||||
EBITDA Margin % | 8.54 | |||||
FCF Margin % | -10.16 | |||||
OCF Margin % | -0.33 | |||||
ROE % | 16.29 | |||||
ROA % | 4.49 | |||||
ROIC % | 9.95 | |||||
3-Year ROIIC % | 8.28 | |||||
ROC (Joel Greenblatt) % | 18.44 | |||||
ROCE % | 33.57 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 38.84 | |||||
PE Ratio without NRI | 38.84 | |||||
Shiller PE Ratio | 106.04 | |||||
PEG Ratio | 0.64 | |||||
PS Ratio | 1.29 | |||||
PB Ratio | 5.8 | |||||
Price-to-Tangible-Book | 5.54 | |||||
EV-to-EBIT | 19.3 | |||||
EV-to-EBITDA | 18.08 | |||||
EV-to-Revenue | 1.55 | |||||
EV-to-FCF | -18.46 | |||||
Price-to-GF-Value | 4.98 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.34 | |||||
Price-to-Graham-Number | 2.87 | |||||
| Price-to-Net-Current-Asset-Value | 162.45 | |||||
Earnings Yield (Greenblatt) % | 5.2 | |||||
FCF Yield % | -8.81 | |||||
Forward Rate of Return (Yacktman) % | 17.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sudarshan Pharma Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,030.565 | ||
| EPS (TTM) (₹) | 0.97 | ||
| Beta | 2.0842 | ||
| 3-Year Sharpe Ratio | 0.88 | ||
| 3-Year Sortino Ratio | 2.73 | ||
| Volatility % | 69.84 | ||
| 14-Day RSI | 29.96 | ||
| 14-Day ATR (₹) | 2.173534 | ||
| 20-Day SMA (₹) | 39.6005 | ||
| 12-1 Month Momentum % | 29.35 | ||
| 52-Week Range (₹) | 18.5 - 42.79 | ||
| Shares Outstanding (Mil) | 249.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sudarshan Pharma Industries Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sudarshan Pharma Industries Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 10:1 Stock Split | 2024-11-22 | 42.15 (-4.04%) |
Show
Entries
Sudarshan Pharma Industries Ltd Frequently Asked Questions
What is Sudarshan Pharma Industries Ltd(BOM:543828)'s stock price today?
The current price of BOM:543828 is ₹32.49. The 52 week high of BOM:543828 is ₹42.79 and 52 week low is ₹18.50.
When is next earnings date of Sudarshan Pharma Industries Ltd(BOM:543828)?
The next earnings date of Sudarshan Pharma Industries Ltd(BOM:543828) is .
Does Sudarshan Pharma Industries Ltd(BOM:543828) pay dividends? If so, how much?
Sudarshan Pharma Industries Ltd(BOM:543828) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sudarshan Pharma Industries Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers